These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 18478764)

  • 21. [Use of molecular biology in the diagnosis of human African trypanosomiasis].
    Jamonneau V; Solano P; Cuny G
    Med Trop (Mars); 2001; 61(4-5):347-54. PubMed ID: 11803825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How to shorten patient follow-up after treatment for Trypanosoma brucei gambiense sleeping sickness.
    Mumba Ngoyi D; Lejon V; Pyana P; Boelaert M; Ilunga M; Menten J; Mulunda JP; Van Nieuwenhove S; Muyembe Tamfum JJ; Büscher P
    J Infect Dis; 2010 Feb; 201(3):453-63. PubMed ID: 20047500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of operational criteria for treatment outcome in gambiense human African trypanosomiasis.
    Mumba Ngoyi D; Lejon V; N'Siesi FX; Boelaert M; Büscher P
    Trop Med Int Health; 2009 Apr; 14(4):438-44. PubMed ID: 19228348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of a PCR assay for diagnosing African trypanosomiasis of the CNS: a case report.
    Kirchhoff LV
    Cent Afr J Med; 1998 May; 44(5):134-6. PubMed ID: 9810412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stage determination and follow-up in sleeping sickness.
    Lejon V; Buscher P
    Med Trop (Mars); 2001; 61(4-5):355-60. PubMed ID: 11803826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human African trypanosomiasis.
    Lejon V; Bentivoglio M; Franco JR
    Handb Clin Neurol; 2013; 114():169-81. PubMed ID: 23829907
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polysomnography as a diagnosis and post-treatment follow-up tool in human African trypanosomiasis: a case study in an infant.
    Mpandzou G; Cespuglio R; Ngampo S; Bandzouzi B; Bouteille B; Vincendeau P; Buguet A
    J Neurol Sci; 2011 Jun; 305(1-2):112-5. PubMed ID: 21470639
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Delivery of antihuman African trypanosomiasis drugs across the blood-brain and blood-CSF barriers.
    Sekhar GN; Watson CP; Fidanboylu M; Sanderson L; Thomas SA
    Adv Pharmacol; 2014; 71():245-75. PubMed ID: 25307219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and Neuropathogenetic Aspects of Human African Trypanosomiasis.
    Kennedy PGE; Rodgers J
    Front Immunol; 2019; 10():39. PubMed ID: 30740102
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Contributions and limits of the diagnosis of human African trypanosomiasis].
    Jamonneau V; Solano P; Koffi M; Denizot M; Cuny G
    Med Sci (Paris); 2004 Oct; 20(10):871-5. PubMed ID: 15461963
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Human African trypanosomiasis, contributions of experimental models].
    Bouteille B; Millet P; Enanga B; Mezui Me J; Keita M; Jauberteau MO; Georges A; Dumas M
    Bull Soc Pathol Exot; 1998; 91(2):127-32. PubMed ID: 9642464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Parasites in the brain? The search for sleeping sickness biomarkers.
    Burchmore R
    Expert Rev Anti Infect Ther; 2012 Nov; 10(11):1283-6. PubMed ID: 23241185
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression and role of CXCL10 during the encephalitic stage of experimental and clinical African trypanosomiasis.
    Amin DN; Rottenberg ME; Thomsen AR; Mumba D; Fenger C; Kristensson K; Büscher P; Finsen B; Masocha W
    J Infect Dis; 2009 Nov; 200(10):1556-65. PubMed ID: 19827943
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment failure related to intrathecal immunoglobulin M (IgM) synthesis, cerebrospinal fluid IgM, and interleukin-10 in patients with hemolymphatic-stage sleeping sickness.
    Lejon V; Robays J; N'Siesi FX; Mumba D; Hoogstoel A; Bisser S; Reiber H; Boelaert M; Büscher P
    Clin Vaccine Immunol; 2007 Jun; 14(6):732-7. PubMed ID: 17428948
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human African trypanosomiasis: use of double centrifugation of cerebrospinal fluid to detect trypanosomes.
    Cattand P; Miezan BT; de Raadt P
    Bull World Health Organ; 1988; 66(1):83-6. PubMed ID: 3260146
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Card agglutination test for trypanosomiasis (CATT) end-dilution titer and cerebrospinal fluid cell count as predictors of human African Trypanosomiasis (Trypanosoma brucei gambiense) among serologically suspected individuals in southern Sudan.
    Chappuis F; Stivanello E; Adams K; Kidane S; Pittet A; Bovier PA
    Am J Trop Med Hyg; 2004 Sep; 71(3):313-7. PubMed ID: 15381812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic characterisation of Trypanosoma brucei s.l. using microsatellite typing: new perspectives for the molecular epidemiology of human African trypanosomiasis.
    Koffi M; Solano P; Barnabé C; de Meeûs T; Bucheton B; Cuny G; Jamonneau V
    Infect Genet Evol; 2007 Dec; 7(6):675-84. PubMed ID: 17704009
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sleeping sickness and the brain.
    Enanga B; Burchmore RJ; Stewart ML; Barrett MP
    Cell Mol Life Sci; 2002 May; 59(5):845-58. PubMed ID: 12088284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of drug resistance in Trypanosoma brucei rhodesiense and Trypanosoma brucei gambiense. Treatment of human African trypanosomiasis with natural products (Review).
    Gehrig S; Efferth T
    Int J Mol Med; 2008 Oct; 22(4):411-9. PubMed ID: 18813846
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trypanosoma brucei gambiense: study of population genetic structure of Central African stocks using amplified fragment length polymorphism (AFLP).
    Simo G; Cuny G; Demonchy R; Herder S
    Exp Parasitol; 2008 Feb; 118(2):172-80. PubMed ID: 17850792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.